Consultants across the Republic of Ireland are being incentivised to prescribe cheaper, biosimilar drugs under a scheme whereby their hospital can keep some of the savings.
Health Service Executive (HSE) Chief Paul Reid said that hospital consultants are being urged to prescribe more cost-effective biosimilar drugs rather than branded alternative medications, where it is possible to do so.
Please register or login to comment!
Register now Login